SciELO - Scientific Electronic Library Online

 
vol.137 número9Gestante con pénfigo foliáceo endémico y producto libre de enfermedad: Caso clínicoDaño cardiovascular por material particulado del aire. Puesta al día 2008 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

ARIAS-CARRION, Oscar. Hypocretin system and narcolepsy. Rev. méd. Chile [online]. 2009, vol.137, n.9, pp.1209-1216. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872009000900012.

Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness, cataplexy, hypnagogic hallucinations, and sleep-onset rapid eye movement (REM) sleep periods. It is now identified as a neurodegenerative disease because there is a massive loss of specific neurons in the brain. These neurons contain the neuropeptides hypocretin-1 and hypocretin-2, which are also known as orexin-A and orexin-B. Cerebrospinal fluid hypocretin-1 measurements are diagnostic for primary narcolepsy. The cause of neural loss could be autoinmune since most patients have the HLA DQB1*0602 alíele that predisposes to the disorders. The discovery of hypocretin deficiency is redefining the clinical entity of narcolepsy and offering novel diagnostic procedures. This article reviews the current understanding of narcolepsy and discusses the implications of hypocretin discovery (Rev Méd Chile 2009; 137:1209-16).

Palabras clave : Hypocretin-1; human; Narcolepsy; Sleep.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons